A Retrospective Cohort Study Comparing Clinical Outcomes and Unscheduled Follow-up of Telemedicine and In-person Medication Abortion
Overview
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Columbia University
- Enrollment
- 400
- Locations
- 1
- Primary Endpoint
- Number of unscheduled follow-ups
Overview
Brief Summary
The objective of this study is to evaluate whether there are different clinical outcomes and unscheduled follow-ups between in-person and telemedicine medication abortion, and to better understand patients' experiences with telemedicine medication abortion and their motivations for seeking unscheduled follow-up care in a setting where abortion care, including both virtual and in-person follow-up care, is readily accessible.
Detailed Description
This study will be retrospective chart review comparing clinical and demographic characteristics, eligibility, treatment success, participation in unscheduled and scheduled follow-ups, and adverse events of patients who obtained a telemedicine medication abortion through the Telehealth Medication Abortion Clinic with patients who received an in-person medication abortion provided at the Family Planning Faculty Practice from June 2023 through September 2024.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Received telemedicine or in-person medication abortion at Columbia University Irving Medical Center's associated practices from June 12, 2023 through September 30, 2024
- •Gestational age \<70 days (based on best obstetrical dating)
- •English or Spanish speaking
Exclusion Criteria
- •Received mifepristone and misoprostol for early pregnancy loss
- •Patient determined to have contraindication to medication abortion
- •Opted for procedural management instead of medication abortion
- •Decided to continue with the pregnancy
- •Presenting for a second medication abortion at CUIMC during the study period
- •Non-English or Spanish speaking
Arms & Interventions
Telemedicine Med Ab
Patients who received medication abortion through the telemedicine medication abortion service during the study period.
Intervention: Telemedicine Medication Abortion (Other)
In-person Med Ab
Patients who received an in-person medication abortion at the clinic during the study period.
Outcomes
Primary Outcomes
Number of unscheduled follow-ups
Time Frame: 3 months after initial encounter
If patients engaged in follow-up are outside of their routinely scheduled follow-up visit 1-2 weeks after medication abortion
Secondary Outcomes
No secondary outcomes reported
Investigators
Erika Levi, MD
Wyeth-Ayerst Associate Professor of Women's Health in Obstetrics and Gynecology
Columbia University